SAN ANTONIO, May 05, 2024 (GLOBE NEWSWIRE) -- Abstracts being presented at the American Urological Association's Annual Meeting discuss how certain diabetes medicine can cause an elevated risk for UTIs in men and how healthcare professionals should work collaboratively to monitor patients on SGLT-2 inhibitors, with attention tailored to patient risk factors including sex.  Researchers will present their study findings covering important updates on diabetes medicine and urologic complications in San Antonio, Texas, from May 3 to 6.

2024年5月5日，圣安东尼奥（环球通讯社）--美国泌尿外科协会年会上发表的摘要讨论了某些糖尿病药物如何导致男性UTI风险升高，以及医疗保健专业人员如何合作监测SGLT-2抑制剂患者，并根据患者风险因素（包括性别）进行关注。研究人员将于5月3日至6日在德克萨斯州圣安东尼奥展示他们的研究结果，涵盖糖尿病医学和泌尿系统并发症的重要更新。

Brian Inouye, MD, assistant professor of surgery/urology at Albany Medical Center, moderated a virtual press session with the abstract authors, providing key insights into their research. “These meds are increasingly popular due to their ability to lower cardiovascular events and the risk of end stage renal disease.

奥尔巴尼医学中心外科/泌尿学助理教授BrianInouye医学博士主持了一场与抽象作者的虚拟新闻发布会，为他们的研究提供了重要见解。“这些药物越来越受欢迎，因为它们能够降低心血管事件和终末期肾病的风险。

They are now first line therapies for diabetes management in patients with cardiovascular disease, chronic kidney disease and heart failure,” said Dr. Inouye. “The ways these meds work is by decreasing the reabsorption of glucose from the urine back into the kidneys and bloodstream. The unintended consequence of this is a higher glucose load in the urine.

他们现在是心血管疾病、慢性肾病和心力衰竭患者糖尿病治疗的一线疗法，”Inouye博士说。“这些药物的作用方式是通过减少尿液中葡萄糖重新吸收回肾脏和血液。其意外后果是尿液中葡萄糖负荷增加。

All three of these talks discuss the urologic sequelae we see in our clinics.” The following abstracts are covered in the moderated panel: SGLT2 Inhibitors Associate with Overactive Bladder SymptomsAssessing the Risk of Urinary Tract Infections Associated with SGLT2 Inhibitors in Men: A VigiBase AnalysisUrologic Complications Of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors Differ Between Diabetic Men And Women A recording of the panel discussion is available to all press registrants.

所有这三次谈话都讨论了我们在诊所看到的泌尿系统后遗症。”主持人小组涵盖了以下摘要：SGLT2抑制剂与膀胱过度活动症状相关，可降低男性SGLT2抑制剂相关尿路感染的风险：VigiBase分析钠-葡萄糖共转运蛋白-2（SGLT-2）抑制剂的泌尿系统并发症糖尿病男性和女性之间的差异小组讨论的记录可供所有新闻注册人使用。

Fill out the registration form on the website to be added to the virtual programming: h.

在网站上填写注册表格以添加到虚拟编程：h。